Immunovant · 20 hours ago
Senior Director, Clinical Pharmacology
Immunovant, Inc. is a clinical-stage immunology company dedicated to enabling normal lives for people with autoimmune diseases. The Senior Director, Clinical Pharmacology is responsible for developing clinical pharmacology plans and overseeing their execution across therapeutic areas, leading the clinical pharmacology and pharmacometrics efforts for various drug development projects.
Responsibilities
Serve as the head of clinical pharmacology and leader of the function for all indications
Develop clinical pharmacology strategy for all Immunovant compounds and design, interpret, and conduct clinical pharmacology studies
Provide clinical pharmacology support for Ph 1, 2, and 3 studies
Support clinical pharmacology aspects of regulatory submissions including writing and review of relevant sections
Provide data analyses, modeling and simulation to support asset development; perform pharmacometrics analyses or provide scientific oversight of pharmacometrics analyses performed by external resources
Collaborate closely with Regulatory to provide CP support of regulatory documents, communications, and presentations as needed (IND, health authority inquires, preparation/participation in meetings with health authorities, preparation of relevant BLA sections, addressing review inquiries, health authority sponsored Advisory Committee Meetings)
Support cross-functional teams, including Statistics, Data Management, Clinical, Preclinical/Nonclinical, Translational Science, as needed
Qualification
Required
PhD, PharmD, or MD with training in CP, PK/PD, Pharmacology, and Pharmaceutical Sciences
8-10 years of experience in the application of CP within the context of drug development in the healthcare industry
Experience in leadership of CP regulatory submission and approvals of at least one original or major NDA/CTDs or multiple supplemental NDA/CTDs (global or regional)
Proven track record of clinical pharmacology and pharmacokinetic / pharmacometrics support for regulatory submissions (e.g., EoP2, IND, NDA, MAA, PIP)
Experience and expertise with pharmacokinetics / pharmacometrics methods and software (e.g, NONMEM, WinNonlin)
Deep understanding of drug development and the integration across the various functions including nonclinical, clinical, CMC, regulatory, finance and legal
Knowledge of regulatory expectations for clinical pharmacology
Excellent written and oral communication skills with meticulous attention to detail
Thrives in a dynamic, interactive, fast-paced, innovative, and entrepreneurial environment
Natural collaborator who enjoys working on a cross-functional team
Benefits
Equity and other forms of compensation may be provided as part of a total compensation package
Full range of medical, dental, vision, 401k, and other benefits
Unlimited paid time off
Parental leave
Company
Immunovant
Immunovant is a clinical-stage biopharmaceutical company focused on enabling normal lives for patients with autoimmune diseases.
Funding
Current Stage
Public CompanyTotal Funding
$1.86BKey Investors
Roivant Sciences
2025-12-11Post Ipo Equity· $550M
2025-01-13Post Ipo Equity· $450M
2023-09-27Post Ipo Equity· $450M
Recent News
2026-01-11
MarketScreener
2026-01-05
Company data provided by crunchbase